E2F1 and E2F7 regulate gastric cancer cell proliferation, respectively, through transcriptional activation and transcriptional repression of MYBL2
Open Access
- 27 November 2024
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (1) , 108027
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81670113)
- China Medical University (1210616002)
This publication has 61 references indexed in Scilit:
- The E2F1–HOXB9/PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancerThe Journal of Pathology, 2023
- E2F1-mediated up-regulation of TOP2A promotes viability, migration, and invasion, and inhibits apoptosis of gastric cancer cellsJournal of Biosciences, 2022
- E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA‐383‐5p transcriptionMolecular Carcinogenesis, 2022
- E2F Transcription Factor 1 Activates FKBP Prolyl Isomerase 4 to Promote Angiogenesis in Cervical Squamous Cell Carcinoma Via the PI3K/AKT Signaling PathwayReproductive Sciences, 2022
- E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult MiceHepatology, 2020
- Receptor tyrosine kinase activation: From the ligand perspectiveCurrent Opinion in Cell Biology, 2020
- Reversal of Multidrug Resistance in Gastric Cancer Cells by E2F‐1 Downregulation In Vitro and In VivoJournal of Cellular Biochemistry, 2013
- Overexpression of E2F-1 inhibits progression of gastric cancer in vitroCell Biology International, 2009
- Co‐regulation of B‐Myb expression by E2F1 and EGF receptorMolecular Carcinogenesis, 2005
- Cell-cycle regulation of human B-myb transcriptionGene, 1995